CellMark Hit With Consent Decree Over Cancer Treatment Ads

Drug Industry Daily
A A
The Federal Trade Commission took CellMark Biopharma to federal court for falsely advertising two of its supplements as “clinically proven” to treat cancer and cancer treatment side effects.

To View This Article:

Login

Subscribe To Drug Industry Daily